Contact Us
Zentraxa, Ltd.
Unit DX
St. Phillips Central, Albert Road
Bristol
BS2 0XJ
United Kingdom
info@zentraxa.com
Follow us:
Twitter: @Zentraxa_Ltd
Follow Us
#PRESS Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins
We are very proud to announce that @ziylo has been acquired by @novonordisk in a deal that could exceed USD$800m. This could lead to the development of a ground-breaking treatment for #diabetes patients, demonstrating the global impact of #Bristol science. https://t.co/mYpslKus26
The Unit DX June newsletter is now online. Featuring @Corr_Associates @Zentraxa_Ltd @kets_quantum @spinup_science @H_Destecroix @RoySocChem @bristoldc @insiderswest @davidclensy #SBT Read it and subscribe - https://t.co/1OwktYenCy
We're really pleased to feature in the latest of the @Unit_DX Science Behind the Technology series. Check it out 👇
#synbio #startup #innovation
The latest episode of the Science Behind the Technology series is online now. This month we interviewed Martin from @Zentraxa_Ltd on their peptide synthesis platform, which could open up a new class of materials using biological production. #SynBio #SBT https://t.co/9kB9erxE0y
The highest ever recorded numbers of spin-outs from @BristolUni. So pleased that @Unit_DX is helping to lower the barrier for the translation of research, while importantly creating more jobs for Bristol scientists. #Bristol #Science #Cluster https://t.co/ooC9oxuflO
